Translate this page into:
Utilisation of Non-pharmacological Interventions for Management of Cancer-related Fatigue in Palliative Care Services – An Audit Cycle
*Corresponding author: Alisha Karim, Department of Clinical Psychology, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh, India. karim.alisha07@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Priyanshu P, Karim A, Fernandes D, Ramani DP, Alapati N, Miriyala R, et al. Utilisation of Non-pharmacological Interventions for management of Cancer-related Fatigue in Palliative care Services – An Audit Cycle. Indian J Palliat Care. 2026;32:207-11. doi: 10.25259/IJPC_440_2025
Abstract
Objectives:
Cancer-related fatigue (CRF) is a debilitating symptom that significantly affects the quality of life of patients with cancer. Effective management requires accurate documentation and timely implementation of non-pharmacological interventions (NPIs), which are considered first-line strategies. This study aimed to assess the documentation of CRF and NPIs in palliative care and evaluate the impact of a standardized operating procedure (SOP) on documentation compliance. The aim of the study is to assess the documentation of CRF and NPIs in palliative care and evaluate the impact of implementing a standardised operating procedure (SOP) on documentation compliance.
Materials and Methods:
A retrospective audit was conducted in two phases: pre–multidisciplinary team (MDT) induction and post-MDT induction, followed by a re-audit after six months. Documentation rates for CRF and NPIs were statistically analysed, and associated symptom clusters were identified using Epi Info software (Version 7.6.2).
Results:
CRF documentation improved from 67% in 2021 to 84% in 2022, and further to 98.5% (February 2023) and 89.3% (March 2023) and 96.7% (September 2023). NPI documentation increased from 0% in 2021 to 36% in 2022, and subsequently to 86.5%, 89.9%, and 86.5% in re-audits. Significant symptom clusters associated with CRF included loss of appetite (p < 0.01), loss of well-being (p < 0.001), and breathlessness (p < 0.01).
Conclusion:
Implementation of an SOP significantly improved CRF and NPI documentation. Identification of key symptom clusters provides important insights for targeted interventions and future research in palliative care.
Keywords
Audit
Cancer-related fatigue
Documentation
Non-pharmacological interventions
Palliative care
Standardised operating procedure
INTRODUCTION
Cancer-related fatigue (CRF) is one of the most pervasive and debilitating symptoms experienced by patients with cancer.[1] The National Comprehensive Cancer Network defines CRF as ‘a distressing, persistent, subjective sense of physical, emotional and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning’.[2] While healthy individuals experience transient fatigue as a physiological response, patients with cancer often endure a relentless and debilitating fatigue that is refractory to rest.[3] The aetiology of CRF is multifactorial and identifying definitive physiological markers for objectively quantifying fatigue is challenging. Therefore, managing CRF necessitates a comprehensive approach that encompasses various components [Table 1].[4]
| Category | Factors |
|---|---|
| Tumour-related factors and complications | Anaemia, electrolyte abnormalities, dehydration, anorexia/cachexia, thrombosis/pulmonary embolism, renal, liver or heart failure, hypoxia, adrenal insufficiencies, neurological deficit, fever |
| Comorbid conditions | Hypothyroidism, diabetes mellitus, chronic obstructive pulmonary disease, heart failure, cardiovascular disease and infections |
| Iatrogenic factors | Chemotherapy, immunotherapy, small-molecule targeted therapies, hormonal therapies, radiotherapy and surgery |
| Physical symptoms | Pain, dyspnoea, difficulty swallowing and appetite loss |
| Psychological/behavioural factors | Anxiety, depression, sleep disorders and decreased physical activity |
| Side effects of other medications | Opioids, psychiatric drugs, antihistamines, beta-blockers and corticosteroids 1 |
In a study by Hofman et al., up to 90% of patients treated with radiation and 80% of those treated with chemotherapy experience fatigue.[5] CRF continues for months and even years following completion of treatment in approximately one third of the patients with cancer. Fabi et al. found that the prevalence of fatigue among survivors undergoing active treatment varies between 62% and 85%, of which 9–45% reported moderate-to-severe CRF.[6,7]
In the Indian scenario, according to Koyyala, CRF is a burden unreported by patients, undiagnosed by physicians and unaddressed in research.[8] Another Indian author found that the presence of CRF was found in all participants with severe fatigue in 97 of 110 patients, with a negative impact on quality of life.[9] Studies conclude that it has a huge impact on daily living activities, leads to social invalidation (cannot/less work, direct role in family and withdraw from activities) and causes psychological problems like anxiety, depression, poor sleep and cognitive disorder.[10]
Recent research has refuted the earlier trend of using rest as management, due to its detrimental effect on the musculoskeletal system,[11,12] cardiopulmonary fitness[13] and functional status.[14] American Society of Clinical Oncology,[15] Canadian Association of Psychosocial Oncology[16] and Evidence-Based Medicine[17] guidelines suggest that management of CRF includes a longitudinal assessment, screening, addressing the underlying causes and following recommendations for interventions.
This implementation necessitates a multidisciplinary team (MDT) approach and comprehensive training.[18] An MDT of doctors, physical therapists, clinical psychologists, social workers, and nurses were inducted within the department of palliative medicine at Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, in December 2021. Phase 1 aimed to audit the documentation of CRF and nonpharmacological interventions (NPIs) to address fatigue before and after MDT induction. Phase 2 audited the impact of the interventions. The research protocol was approved by the Institutional Ethics Committee (P. No. 12000039).
Primary objectives
To study the documentation of CRF
To study the documentation of the NPIs done for CRF.
Secondary objectives
To study the symptom clusters associated with fatigue.
Set standard
100% patients with a diagnosis of cancer seen on palliative consult should have documentation of the presence/absence of CRF in their case sheets
-
100% of patients with CRF documentation should have NPI documented.
The set standards for audit are 100% for both criteria.
MATERIALS AND METHODS
Inclusion criteria
Patients with a definitive diagnosis of cancer seen in the outpatient department, inpatient department or home care
Patients of the age group ≥18 years
Patients who were capable of comprehending/answering.
Exclusion criteria
Proxy visits
Study duration
18 months.
Phase 1
The audit comprised two different phases. In Phase 1 of the audit cycle, data were collected in two distinct periods: before and after the induction of an MDT – March 2021 and March 2022, respectively.
Subsequently, the results were analysed and changes were instigated [Table 2]. We developed the standardised operating procedure (SOP) for the department, which included specific codes for ease of NPI documentation [Table 3]. These codes were designed based on the severity of reported CRF. Patients falling into categories of mild, moderate or severe fatigue, as assessed by the numerical rating scale of the Edmonton Symptom Assessment System[19], received tailored interventions.
| Action | Details |
|---|---|
| Training and sensitisation | All department staff received training and sensitisation. |
| Documentation checklist | A daily checklist was implemented to ensure code documentation in the electronic medical record. |
| Code reinforcement | Both new and existing staff were reminded about the codes and non-pharmacological intervention documentation. For easy reference, the codes were prominently displayed on the department board. |
| Mild fatigue (NRS 1–3) NPI F1 | Moderate fatigue (NRS 4–6) NPI F2 |
| • Education and counselling - Fatigue is a part of the disease and its trajectory - Fatigue caused due to the disease is irreversible with just rest. • Counselling for continuing the daily activities. • Pacing your daily activities • Delegate |
• Education and counselling remain the constant - Following a structured routine to avoid exertion - Using assistive devices (Walker, Wheelchair) -Self-monitoring and maintaining a diary to evaluate for peak fatigue. • Structured physical therapist interventions - Reconditioning exercises customised for patients by the Physiotherapist. - Initiation of physical activity (Aerobic training, namely walking, cycling, swimming, jogging, gardening, etc.) - Active range of motion and strengthening exercises - Endurance training. |
| Severe fatigue (NRS ≥7) NPI F3 | Fatigue at end-of-life NPI FE |
| • Using assistive devices to maximum • Rest • Positioning • Cautions in doing physical activity: Bone metastasis, thrombocytopenia, anaemia, fever, active • Infection or post-surgery • Correct the correctable • Limitations secondary to metastasis or other comorbid illness, safety issues (i.e., assessment of fall risks) • Maintaining an optimal level of physical activity and strength |
• Rest and comfortable positioning • Provide bedside-assistive devices • Complete elimination of non-essential activities • Conserve energy for valued activities • Effective symptom management • Address emotional distress • Optimise treatment for sleep dysfunction |
CRF: Cancer-related fatigue, NRS: Numerical rating scale, NPI: Non-pharmacological intervention
General strategies of management remain the same at all the stages, except for patients with end-of-life fatigue.
Education, counseling
Self-monitoring of fatigue
Initiation of physical activity.
Phase 2: Re-audit
Two follow-up audits were conducted to assess the effectiveness of the implemented changes. The first audit occurred 1 month after implementation, with data collected from February to March 2023. To ensure sustainability, a second audit followed in September 2023.
RESULTS
Phase 1
In March 2021 (n = 391), documentation of CRF was observed in only 67% of cases, which increased to 84% in March 2022 (n = 433). From no documentation of NPI in 2021, it increased to 36% with the MDT [Figure 1].

Phase 2
Documentation of both CRF and NPI increased during the re-audit phase. February 2023 (n = 478) CRF documentation was observed in 98.5% of which NPI was given for 86.5% of individuals. Similarly, in March 2023 (n = 600), both CRF and NPI documentation were 89.3% and 89.9%, respectively. To assess the compliance and sustainability, the re-audit that followed after 6 months showed 96.7% of CRF documentation with 86.5% of NPI documentation [Figure 2].

Significant symptom clusters associated with fatigue were loss of appetite (p < 0.01), loss of well-being (p < 0.001) and breathlessness (p < 0.01).
DISCUSSION
The results of the audit reveal a notable evolution in the documentation of CRF and NPIs within the department over the specified time period. Initially, the documentation of CRF was observed in only 67% of cases, highlighting a discrepancy in clinic practice. In March 2022, following an intervention involving the introduction of MDT and the establishment of an SOP, documentation improved to 84%. A marked absence of NPI documentation in 2021 was noted which increased only to 36% with the MDT. It was the team sensitisation, training and the introduction of specific codes for NPI documentation based on the severity of fatigue which has positively influenced this improvement. Documentation increased significantly from February 2023 (98.5%) to September 2023 (96.70%). This indicates a substantial improvement in capturing fatigue during this period.
A notable increase in CRF documentation is evident with an interesting trend seen in the reaudit phase, which is the increased number of patients reporting fatigue, which suggests that improved documentation could be contributing to a higher reporting rate, improving the identification of patients who could benefit from NPIs [Figure 2]. This is pivotal, given the challenges in recognising and treating CRF, as those suffering often consider fatigue to be an inevitable side effect of their disease and its treatment.[11-14]
NPIs documentation also showed improvement in 2023. There was a sustained improvement from February 2023 (86.5%) to March 2023 (89.9 %) and September 2023 (86.50%). However, the increase was not as dramatic as CRF documentation [Figure 2].
The audit also highlighted the importance of education and sensitisation of staff regarding the critical role of NPI such as exercise, relaxation techniques and psychological support, in managing CRF.[20] The integration of these interventions aligns with the broader literature acknowledging their efficacy in palliative care settings.[5-7]
Implementation of the MDT and SOP has significantly enhanced CRF documentation, corroborating existing literature on the efficacy of collaborative care.[18] The instigation of daily checklists, code reinforcement sessions and visible reminders within the department served as efficient methods for promoting consistent documentation. The correlation between fatigue and symptom clusters such as loss of appetite, loss of well-being and breathlessness corroborates existing literature which suggests that CRF is seldom an isolated symptom and often presents in association with other distressing symptoms.[21]
The data in Table 4 offer a snapshot of the distribution of severity trends over the given timeline. With a sample size of 1619 cases, the majority were classified as mild (53%), followed by moderate (36%), and as severe (12%) with a notable concentration of individuals within the 50–70% palliative performance scale range during both the phases. Early NPI F1 interventions were initiated in a small subset (3%) of patients who did not report fatigue, emphasising a proactive approach to patient care by educating, counselling and preserving functionality. While a substantial proportion of patients with mild (87.3%) and moderate (78.9%) fatigue received appropriate NPI F1 and NPI F2 interventions, respectively, the data underscore the challenges in aligning subjective patient-reported fatigue with objective clinical assessment. This inconsistency is evident in cases where intervention levels were adjusted based on functional status, disease trajectory and patient capacity rather than solely on reported fatigue severity. In NPIs, implementation for the severe fatigue group (71% for NPI F3) with a clear end-of-life care pathway (9.7% Non Pharamacological Intervention Fatige End of life [NPI FE]) is seen. A critical next step is to evaluate the impact of these interventions on patient outcomes. This evaluation is essential to determine the effectiveness of the current approach and to identify areas for improvement.
| Severity | n=1619 (%) |
|---|---|
| Mild | 851 (53) |
| Moderate | 574 (36) |
| Severe | 194 (12) |
CRF: Cancer-related fatigue
Severity trend along the 2nd phase (February, March and September 2023) was seen as such [Table 4].
CONCLUSION
This study underscores the importance of developing contextual codes for ease of documentation. The implementation of MDT approach, coupled with targeted educational interventions, has led to substantial improvements in the documentation of CRF and NPIs. The symptom cluster associated with CRF emphasises the importance of longitudinal assessment.
Ethical approval:
The research/study was approved by the Institutional Review Board at Homi Bhabha Cancer Hospital and amp; Research Centre, approval number IEC/0224/12000039/001, dated 15th February 2024.
Declaration of patient consent:
Patient’s consent is not required as there are no patients in this study.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Bone tired: The experience of fatigue and its impact on quality of life. Oncol Nurs Forum. 1996;23:1539-47.
- [Google Scholar]
- NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue, Version I. 2017. Available from: https://www.nccn.org/professionals/physiciangls/pdf/fatigue [Last accessed on 2025 Nov 26]
- [Google Scholar]
- Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol. 2000;11:971-5.
- [CrossRef] [PubMed] [Google Scholar]
- Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl):11-20.
- [CrossRef] [PubMed] [Google Scholar]
- Cancer patients' expectations of experiencing treatment-related side effects: A University of Rochester cancer center--community clinical oncology program study of 938 patients from community practices. Cancer. 2004;101:851-7.
- [CrossRef] [PubMed] [Google Scholar]
- Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol. 2020;31:713-23.
- [CrossRef] [PubMed] [Google Scholar]
- Prevalence and causes of fatigue after cancer treatment: The next generation of research. J Clin Oncol. 2005;23:8280-2.
- [CrossRef] [PubMed] [Google Scholar]
- Cancer-related fatigue: A burden unreported by patients, undiagnosed by physicians, and unaddressed in research. Cancer Res Stat Treat. 2021;4:121-3.
- [CrossRef] [Google Scholar]
- To assess the prevalence and predictors of cancer-related fatigue and its impact on quality of life in advanced cancer patients receiving palliative care in a tertiary care hospital: A cross-sectional descriptive study. Indian J Palliat Care. 2020;26:523-7.
- [CrossRef] [PubMed] [Google Scholar]
- Dissemination and implementation of guidelines for cancer-related fatigue. J Natl Compr Canc Netw. 2016;14:1336-8.
- [CrossRef] [PubMed] [Google Scholar]
- Muscle strength during bedrest with and without muscle exercise as a countermeasure. Eur J Appl Physiol. 1995;71:342-8.
- [CrossRef] [PubMed] [Google Scholar]
- Physiological consequences of reduced physical activity during bed rest. Exerc Sport Sci Rev. 1982;10:84-119.
- [CrossRef] [PubMed] [Google Scholar]
- Cardiac atrophy after bed-rest deconditioning: A nonneural mechanism for orthostatic intolerance. Circulation. 1997;96:517-25.
- [CrossRef] [PubMed] [Google Scholar]
- Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum. 1994;21:23-36.
- [Google Scholar]
- Cancer-related fatigue: Appraising evidence-based guidelines for screening, assessment and management. Support Care Cancer. 2016;24:3935-42.
- [CrossRef] [PubMed] [Google Scholar]
- A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol. 2013;20:e233-46.
- [CrossRef] [PubMed] [Google Scholar]
- Training general practitioners contributes to the identification of palliative patients and to multidimensional care provision: Secondary outcomes of an RCT. BMJ Support Palliat Care. 2019;9:e18.
- [CrossRef] [PubMed] [Google Scholar]
- The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6-9.
- [CrossRef] [PubMed] [Google Scholar]
- A pain management program for chronic cancer-treatment-related pain: A preliminary study. J Pain. 2006;7:82-90.
- [CrossRef] [PubMed] [Google Scholar]
- A randomized, placebo-controlled, double-blind study of minocycline for reducing the symptom burden experienced by patients with advanced pancreatic cancer. J Pain Symptom Manage. 2020;59:1052-8.e1.
- [CrossRef] [PubMed] [Google Scholar]

